Sjögren's disease & overlap diseases

Interstitial lung disease in mixed connective tissue disease: Insights from an electronic health record-based retrospective cohort study

Semin Arthritis RheumPublished Retrospective cohort study

Authors' conclusion

ILD affected roughly half of patients with MCTD in this EHR-based cohort. PH and older age were independently associated with ILD

Study context

Population
Adults with mixed connective tissue disease (MCTD) (adapted Kasukawa classification algorithm) evaluated at a large urban academic medical center, 2014–2026
Participants
120 adults
Exposure
Clinical features associated with interstitial lung disease (ILD) presence in MCTD
  • ILDn = 61
Outcome
Predictors of ILD presence in MCTD
Methodological detailsElectronic health record (EHR)-based, single-centre, multivariable logistic regression, Cox proportional hazards with time-dependent ILD status, prespecified sensitivity analysis
  • EHR-based
  • Single-centre
  • Multivariable logistic regression
  • Cox proportional hazards with time-dependent ILD status
  • Prespecified sensitivity analysis

Main finding

As reported in the abstract

ILD

50.8%

61

Odds ratio (95% CI)P value
PHindependently associated with ILD
5.10(1.91–13.63)
P = 0.001
Age 55-74 yearsindependently associated with ILD
7.61(1.74–33.33)
P = 0.007
GERDdid not reach statistical significance after adjustment
3.16(0.92–10.79)
P = 0.067

Observational data: associations, not effects.

Further findings

Mortality by ILD status (survival analysis, n = 120, 11 deaths)

EstimateP value
ILDtime-dependent HR 2.57 (95% CI 0.74–8.94)P = 0.137
ILDage-adjusted HR 2.60 (95% CI 0.75–9.03)P = 0.134

Original publication

Interstitial lung disease in mixed connective tissue disease: Insights from an electronic health record-based retrospective cohort study. Semin Arthritis Rheum. Published 11 July 2026. doi:10.1016/j.semarthrit.2026.153043

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.